ReachRxResearch
Home
Research
Sign Up
Early diagnosis of axial spondyloarthritis is associated with less long‐term spinal structural damage: a longitudinal analysis of the Swiss Clinical Quality Management in rheumatic diseases registry
Back to Research Hub
  1. Home
  2. Research Hub
  3. Early diagnosis of axial spondyloarthrit…

Early diagnosis of axial spondyloarthritis is associated with less long‐term spinal structural damage: a longitudinal analysis of the Swiss Clinical Quality Management in rheumatic diseases registry

Arthritis & Rheumatology·September 18Open Access
RheumatologyPractice changingAxial SpondyloarthritisLongitudinal Cohort StudyBiologic TherapyDisease-Modifying Antirheumatic DrugAdult

Summary

View source

What was studied

Whether early diagnosis of axial spondyloarthritis (axSpA; symptom duration ≤2 years) vs. established axSpA is associated with less long-term spinal radiographic progression, assessed over a mean 11.5 years in the Swiss SCQM registry (2004–2024) using mSASSS scores.

Key findings

Early axSpA patients had significantly less long-term spinal structural damage than established axSpA patients (−3.85 mSASSS units, 95% CI −7.28 to −0.42; adjusted for baseline damage: −5.70 units, 95% CI −9.31 to −2.09), with the difference becoming apparent 10–15 years after diagnosis.

Study limitations

Observational registry design limits causal inference; treatment was standard of care rather than randomized, introducing potential confounding; the difference only emerged after 10–15 years, requiring very long follow-up to detect.

Clinical implications

Diagnosing axSpA within 2 years of symptom onset is linked to meaningfully less spinal structural damage over a decade or more. Clinicians should pursue early identification and treatment of axSpA to help prevent long-term radiographic progression.

Caveats

  • The benefit of early diagnosis only became statistically apparent 10–15 years after diagnosis, so findings may not apply to shorter follow-up clinical contexts
  • The cohort had a male predominance (61%) and high HLA-B27 positivity (69%), which may limit generalizability to more diverse axSpA populations
  • This is an observational registry study; treatment decisions were not randomized, and unmeasured confounders (e.g., disease severity at baseline, specific drugs used) may influence results

Related Questions

Explore related topics

How does early versus delayed treatment in axial spondyloarthritis affect long-term radiographic outcomes?What are the best strategies for early diagnosis of axial spondyloarthritis in primary care?Does biologic therapy in early axSpA slow spinal radiographic progression compared to NSAIDs alone?

Publication Details

Year
2026
Journal
Arthritis & Rheumatology
Sample Size
n=376
Source
View article
Keep scrolling
More content below.
Up Next